Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/29/2003US20030100076 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis
05/29/2003US20030100074 Nucleotide sequences coding polypeptide for use in treatment, diagnosis and prevention of bone disorders
05/29/2003US20030100071 Polypeptide for use in the prevention and treatment of bacterial infections
05/29/2003US20030100067 Expression of preferential protein in lactobacillus; provide nutrient broth, inoculate with bacteria, transform with vector which express preferential protein and regulatory sequences, express sequences recover proteins
05/29/2003US20030100066 Propagation of genetically engineered eukaryotic cells; generate nutrient broth, inoculate with plant cutting, propagate cells, transfrom cell, monitor gene expression in cells
05/29/2003US20030100065 Enzymatic polypeptide for use as tool in the fermentation of alcohols
05/29/2003US20030100062 Nucleotide sequences coding polypeptide for use in the treatment of arthritis, osteoporosis, liver, diabetic and inflammatory bowel diseases
05/29/2003US20030100061 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030100060 Cloning, expression, sequencing, and functional enhancement of monoclonal ScFv antibody against venzuelan equine encephalitis virus (VEE)
05/29/2003US20030100059 Novel cell-based assays for G-protein-coupled receptor-mediated activities
05/29/2003US20030100056 Nnucleotide sequences coding polypeptide for use in the treatment of obesity and diabetes
05/29/2003US20030100054 Nucleotide sequences coding polypeptide associated with biosynthesis of leucine, valine, isoleucine and phenylalanine; for use in food processing; for use in animal nutrients
05/29/2003US20030100053 Nucleotide sequences coding polypeptide for use in the treatment of tumor disorders
05/29/2003US20030100052 Method for cloning and expression of BsmBI restriction endonuclease and BsmBI methylase in E. coli and purification of BsmBI endonuclease
05/29/2003US20030100050 Nucleotide sequences for use as regulatory tools in genetic engineering
05/29/2003US20030100049 AKT nucleic acids, polypeptides, and uses thereof
05/29/2003US20030100048 T1 receptor-like ligand ii polypeptides
05/29/2003US20030100045 Nucleotide sequences coding polypeptide for use in carotenoid biosynthesis
05/29/2003US20030100039 Novel human phospholipase c delta 5
05/29/2003US20030100037 Detection of modulators of preferential enzymatic activity; obtain enzymatic polypeptide, incubate with test modulator, monitor association or dissociation of polypeptides, dissociation indicates presence of modulator
05/29/2003US20030100034 Detection of modulators of cell activity; obtain cell, incubate with modulator, measure the concentration of target polypeptide, evaluate for cancer
05/29/2003US20030100031 Integrative assays for monitoring molecular assembly events
05/29/2003US20030100026 Stimulus-inducible protein kinase complex and methods of use therefor
05/29/2003US20030100025 Detection of inhibitors of ecdysteroid biosynthesis; obtain ecdysteroid biosynthetic enzyme, incubate with modulator, monitor adjustment in enzyme activity, reduction in enzyme activity indicates inhibitor of ecdysteriod biosynthesis
05/29/2003US20030100023 Immunoassay and antibody selection methods using cell surface expressed libraries
05/29/2003US20030100022 Nucleic acid construct system and method utilizing same useful for identifying protein-protein interactions
05/29/2003US20030100021 Genetically engineered receptor for use in the detection and analysis of protein binding activity
05/29/2003US20030100007 Detection of preferential binding agents; form peptide library, incubate target, recover peptide which bind to target, expose target to non-peptide binding agent, recover bound target, determine structure of nonpeptide binding agent
05/29/2003US20030099998 Development of method for screening physiologically active pyrrole imidazole derivative
05/29/2003US20030099992 Genes associated with mast cell activation
05/29/2003US20030099991 Detection of nucleotide sequences associated pain and nervous system disorders; obtain sample, incubate with probe, detect signal, recover nucleic acid, incubate with primer, amplify, evaluate for disorder
05/29/2003US20030099990 TALL-1 receptor molecules and uses thereof
05/29/2003US20030099989 Fluorescent probes for chromosome painting
05/29/2003US20030099984 Isolating nucleic acid encoding a plant polypeptide for use in generating disease resistant plants; obtain library, incubate with probe, recover clone, transform plant, propagate, evaluate for disease resistance
05/29/2003US20030099978 Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)
05/29/2003US20030099976 Androgen receptor complex-associated protein
05/29/2003US20030099971 Epidermal differentiation factor
05/29/2003US20030099970 Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof
05/29/2003US20030099966 Determination of sequence of preferential nucleic acid polymers; obtain bacterial nucleotide sequences, sequence and classify nucleic acid polymer
05/29/2003US20030099964 Methods for genomic analysis
05/29/2003US20030099963 Nucleotied sequences coding polypeptide for use in the diagnosis and treatment of cancer
05/29/2003US20030099962 Generation of preferential vector; obtain single stranded nuclleotide sequences, incubate with primers, nucleotides and polymerase, generate nucleotide sequences, recover nucleotide sequences and regenerate vector
05/29/2003US20030099961 Nucleotide sequences for use as amplification tools in genetic engineering
05/29/2003US20030099959 Cooperative oligonucleotides
05/29/2003US20030099956 Ligation of nucleotide sequence in sample; obtain nucleotide sequence sample, incubate with primer, polymerase and nucleotide triphosphates, amplify sequences, digest, ligate and recover nucleotide sequence product
05/29/2003US20030099954 Adjusting preferential biopolymers; obtain biopolymer sample, insert into analytical apparatus, heat and adjust biopolymer
05/29/2003US20030099949 Generation of solid support for use in the analysis of preferential particles; prepare slurry, deposit on substrate and microparticles, immobilze particles and form matrix, recover solid sopport
05/29/2003US20030099946 Detection of fungal pathogens using the polymerase chain reaction
05/29/2003US20030099945 Parallel selex
05/29/2003US20030099942 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
05/29/2003US20030099939 Nucleic acid ladders
05/29/2003US20030099933 Monitoring toxicity of drug treatment in humans; obtain blood sample, determine mitochondrial concentration, compare to control, adjustment in concentration indicates drug toxicity
05/29/2003US20030099932 Expression vector for as gene transfer and diagnostic tool in genetic engineering
05/29/2003US20030099926 Response element compositions and assays employing same
05/29/2003US20030099925 Solid support for use in detection and analysis of gene interation in eukaryotes
05/29/2003US20030099697 Amphoteric liposomes and their use
05/29/2003US20030099685 Implant comprising a material suitable for use in vivo within a subject in combination with osteopontin; enhanced rate of osseointegration and/or augmented percentage of bone apposition around implants
05/29/2003US20030099673 Use of such polypeptides and nucleic acids encoding them as vaccines and diagnostic reagents
05/29/2003US20030099671 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
05/29/2003US20030099670 Comprises RNA-sequence encoding modified RNA-polymerase due to wild-type point mutations apy; genetic engineering; immunotherapy
05/29/2003US20030099669 Method of protein production using mitochondrial translation system
05/29/2003US20030099667 Virus modified by the insertion of cDNA of serotypes
05/29/2003US20030099662 Proteins
05/29/2003US20030099661 Compositions and methods for the treatment of immune related diseases
05/29/2003US20030099660 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
05/29/2003US20030099656 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
05/29/2003US20030099654 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss
05/29/2003US20030099653 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
05/29/2003US20030099652 Novel human protein tyrosine kinase
05/29/2003US20030099646 For interfering with cyclin expression or phosphorylation via map-kinase; hybridomas; antitumor agents; antiproliferative agents
05/29/2003US20030099631 A metalloprotease having a proteolytic activity; treating various diseases such as diabetic nephropathy, glomerulonephritis, fibrosis, cirrhosis, osteopetrosis and herniated disk; drug screening kits
05/29/2003US20030099628 Preventing proliferation of a tumor, using heparinase III; use sequencing heparin-like glycosaminoglycans (HLGAGs), removing active heparan sulfate from a solution, inhibition of angiogenesis
05/29/2003US20030099627 Method for determining modulation of p110delta activity
05/29/2003US20030099619 Method and composition for targeting an adenoviral vector
05/29/2003US20030099618 Administering a genetic engineered virus virions, comprising a nucleotide sequence able to code antihemophilic factor protein; patient's blood will able to clot
05/29/2003US20030099617 Method for using thymosin beta-10 for gene therapy of solid malignant tumors
05/29/2003US20030099616 Synergistically targeting the malignant cells, transduction of the vector into a mammalian cell, gene expressing telomerase reverse transcriptase causes killing of the cancer cell; genetic engineering
05/29/2003US20030099615 Porcine adenovirus E1 and E4 regions
05/29/2003US20030099614 2-Methoxyestradiol-induced apoptosis in cancer cells
05/29/2003US20030099613 An encoded repressor or activator and a viral nucleotide sequence for replication; preparing a vaccine for the prophylaxis of AIDS, human immunodeficiency virus
05/29/2003US20030099612 Genetic engineered human light chain polypeptide for treating disorders associated with cell proliferation; using agonists, antagonists, polynucleotide, or antibodies; specific binding
05/29/2003US20030099611 Manipulation and detection of protein phosphatase 2c-pp2calpha - expression in tumor cells for cancer therapy, prevention and detection
05/29/2003US20030099609 Canine IL-4 nucleic acid molecules and uses thereof
05/29/2003US20030099608 Human cytokine receptor
05/29/2003US20030099607 Ifn-y production inducing protein (igif, il-18)
05/28/2003EP1315099A1 Microbe analyzing system and method, and database
05/28/2003EP1314787A2 The Midkine gene is associated with cancer
05/28/2003EP1314785A1 Nucleic acids and proteins showing increased expression dose under salt stress
05/28/2003EP1314784A1 G-protein coupled receptor LUSTR2 and uses thereof
05/28/2003EP1314783A1 Nucleic acid linkers and their use in gene synthesis
05/28/2003EP1314782A1 Process for producing biopterins
05/28/2003EP1314780A1 Collagen-binding hybrid polypeptide
05/28/2003EP1314779A1 Airway-specific trypsin-like enzymes and method of using the same
05/28/2003EP1314741A1 Bispecific anti-CD19 x anti-CD16 antibodies and uses thereof
05/28/2003EP1314738A1 Pseudovirons comprising virus capsids, histones and nucleic acids as therapeutic agents
05/28/2003EP1314352A1 Transgenic mammals
05/28/2003EP1314040A2 Use of grf1 protein for screening molecules
05/28/2003EP1314039A2 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type
05/28/2003EP1313885A2 Methods of using agents that modulate bone formation and inhibit adipogenesis
05/28/2003EP1313884A2 Improvements in and relating to marking using dna
1 ... 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 ... 4023